Shots:
- SMA Foundation and PTC will provide an initial investment of up to $60M in research to discover & develop regenerative treatments in neuromuscular diseases
- The focus of the agreement is advance scientific research in SMA and other neuromuscular disorders to develop new treatments
- The availability of several disease-modifying therapies has made regenerative interventions the next frontier in drug discovery and development
Click here to read full press release/ article | Ref: PRNewswire | Image: Wikipedia
The post SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine first appeared on PharmaShots.